TSC Alert

Archive for the ‘Research Resources’ Topic

Compound Nominations Open for Epilepsy Screening

The TSC Preclinical Consortium Steering Committee is seeking compound nominations for the Tsc1flox/flox;GFAP-Cre+ (GFAP-Tsc1-CKO) (epilepsy) mouse model. To nominate a compound, please submit the Compound Nomination form. The Preclinical Consortium Steering Committee sets the long-term goals, and Working Groups decide the best models and experimental design for drug testing and provide oversight for rigorous quality control and interpretation of results. Compounds are handled and tested by experienced contract research organizations, and data are shared among the Consortium. Any researcher may propose compounds for testing and benefit from the shared data. For-profit companies interested in nominating compounds and retaining confidentiality and ownership…

Now Accepting Nominations for Preclinical Testing

Nominations accepted until Friday, June 10, 2022  Interested principal investigators (PI) are invited to nominate candidate therapeutics for testing in the TSC Preclinical Consortium’s tumor models. Please complete the short nomination form, available on the TSC Alliance Preclinical Consortium webpage. The form requests no more than two pages of text and/or figures to describe the rationale for the compound and its mechanism of action for TSC. The lead PI must also submit an NIH-style biosketch. Nominations will be accepted until Monday, August 1, 2022.   Companies interested in nominating compounds and retaining confidentiality and ownership of the data should not utilize the nomination…

TSC Alliance® Partners with NeurologyLive™

The TSC Alliance has partnered with NeurologyLive to bring healthcare professionals treating neurological disorders the latest in research and practice. Check out our partner page. Subscribe to NeurologyLive to stay up to date on clinical trial news, FDA updates and more.